サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1553431

家庭用睡眠時無呼吸検査の市場規模、シェア、動向分析レポート：地域別、セグメント予測、2024年～2030年

Home Sleep Apnea Test Market Size, Share & Trends Analysis Report By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa), And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
家庭用睡眠時無呼吸検査の市場規模、シェア、動向分析レポート：地域別、セグメント予測、2024年～2030年
出版日: 2024年08月13日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

家庭用睡眠時無呼吸検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の家庭用睡眠時無呼吸検査市場規模は、2024年から2030年にかけてCAGR 6.4%で成長し、2030年には33億8,000万米ドルに達する見込みです。

市場成長の背景には、家庭用睡眠時無呼吸検査（HSAT）の技術的進歩を目的とした、著名企業による投資の増加があります。例えば、2024年3月、Belun Technology Company Ltd.は、Belun Ringプラットフォームの評価を目的とした臨床試験を開始しました。ウェアラブル技術であるBelun Ringは、人工知能（AI）を採用し、閉塞性睡眠時無呼吸症候群（OSA）の診断や睡眠相の分類において医療専門家を支援します。自宅での睡眠評価には、パルスオキシメーターと加速度計を内蔵し、人差し指近位部に装着するこのリング型デバイスを使用します。

さらに、睡眠時無呼吸症候群の有病率の増加と、睡眠時無呼吸症候群を治療するための技術的に高度なソリューションの利用可能性に関する認識を高めることを目的としたイニシアチブの拡大も、市場の成長に寄与しています。2024年5月にNational Council on Aging, Inc.が発表したデータによると、約600万人の米国人が正式に睡眠時無呼吸症候群と診断されているが、この症状は米国内で3,000万人に影響を与えると推定されています。睡眠時無呼吸症候群の有病率は年齢とともに増加する傾向があり、研究によると65歳以上の成人は閉塞性睡眠時無呼吸症候群を発症するリスクが56％高いことが示されています。

COVID-19は、エンドユーザーに遠隔医療ソリューションの採用を促し、市場にプラスの影響を与えました。Itamar MedicalがSleep Medicine Publicationと提携して2021年3月に実施した調査によると、睡眠クリニックの29%が自宅でのソリューションよりもラボでの検査を優先しており、この割合はさらに低下すると予想されています。このシフトは、返送や機器の検疫の必要がない使い捨ての家庭用睡眠時無呼吸検査（HSAT）の採用によって支えられています。即座に結果が得られる家庭用無呼吸検査の機能が強化されたことで、最初のスクリーニングから診断、治療に至るまで、患者の経過を従来の検査室での検査に依存する傾向がさらに弱まった。パンデミックの間、クリニックの67％が検査室での患者検査が中程度から大幅に減少したと報告したのに対し、66％は家庭用睡眠時無呼吸検査の利用が同程度増加したと指摘しました。65％の診療所がCOVID後もこの傾向が続くと予測しており、睡眠時無呼吸症候群の主要な診断手段としてHSATを選好しています。

さらに、市場の主要企業は、エンドユーザーの進化する需要に対応し、市場での地位を強化するために、M&A、パートナーシップ、提携、事業拡大、新製品の発売など、さまざまな戦略を採用しています。例えば、2023年3月、英国を拠点とする医療技術企業Acurable社は、最近のFDA承認を受けて、米国で閉塞性睡眠時無呼吸症候群の診断用AcuPebbleデバイスを発売し、市場範囲を拡大しました。2021年に欧州で最初に導入されたこのデバイスは、遠隔地での家庭用睡眠時無呼吸検査機能を強化し、迅速な診断、治療の促進、状態の管理改善を促進します。

家庭用睡眠時無呼吸検査市場レポート・ハイライト

  • 2023年の市場シェアは北米が47.74％で最大。市場成長の背景には、呼吸器疾患の罹患率の上昇、閉塞性睡眠時無呼吸症候群（OSA）の認知度向上、市場成長を後押しする政府の支援政策があります。
  • アジア太平洋市場は、2024年から2030年にかけてCAGR 8.0％で最速の成長率を記録すると予想されています。この成長は、同地域で技術的に先進的なHSATが大幅に採用されていることに起因しています。
  • 主要企業は、サービス・ポートフォリオを拡大し、地理的プレゼンスを強化するために、製品発売、提携、買収、合併など様々な戦略を採用しており、市場内での大きな競合につながっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 家庭用睡眠時無呼吸検査市場の変数、動向、範囲

  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
  • 家庭用睡眠時無呼吸検査市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 家庭用睡眠時無呼吸検査市場：地域推定・動向分析、製品別、用途別、最終用途別

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界地域市場スナップショット
  • 市場規模、予測動向分析、2018年から2030年：
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第5章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • 主要企業の市場シェア/ポジション分析、2023年
  • 企業プロファイル
    • Resmed
    • Itamar Medical Ltd a subsidiary of ZOLL Medical Corporation（a ASAHI KASEI company）
    • Cleveland Medical Devices Inc.
    • Compumedics Limited
    • Onera Technologies BV
    • Sunrise
    • Nox Medical
    • Watermark Medical
    • Bittium
    • Cadwell Industries Inc.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 3 U.S. Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 4 Canada Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 5 Mexico Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 6 Europe Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 7 Germany Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 8 UK Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 9 France Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 10 Italy Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 11 Spain Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 12 Denmark Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 13 Sweden Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 14 Norway Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 15 Asia Pacific Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 16 China Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 17 Japan Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 18 India Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 19 South Korea Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 20 Australia Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 21 Thailand Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 22 Latin America Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 23 Brazil Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 24 Argentina Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 25 MEA Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 26 South Africa Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 27 Saudi Arabia Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 28 UAE Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 29 Kuwait Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Home Sleep Apnea Test Market outlook
  • Fig. 9 Home sleep apnea test competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Home Sleep Apnea Test Market driver impact
  • Fig. 15 Home Sleep Apnea Test Market restraint impact
  • Fig. 16 Home Sleep Apnea Test Market strategic initiatives analysis
  • Fig. 17 Global Home Sleep Apnea Test Market: Regional movement analysis
  • Fig. 18 Global Home Sleep Apnea Test Market: Regional outlook and key takeaways
  • Fig. 19 Global Home Sleep Apnea Test Market share and leading players
  • Fig. 20 North America market share and leading players
  • Fig. 21 Europe market share and leading players
  • Fig. 22 Asia Pacific market share and leading players
  • Fig. 23 Latin America market share and leading players
  • Fig. 24 Middle East & Africa market share and leading players
  • Fig. 25 North America: SWOT
  • Fig. 26 Europe SWOT
  • Fig. 27 Asia Pacific SWOT
  • Fig. 28 Latin America SWOT
  • Fig. 29 MEA SWOT
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 37 France market estimates and forecasts, 2018 - 2030
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 44 China market estimates and forecasts, 2018 - 2030
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 46 India market estimates and forecasts, 2018 - 2030
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 58 Market share of key market players- Home Sleep Apnea Test Market
  • Fig. 59 Key Company Categorization
  • Fig. 60 Company Market Share/Position Analysis, 2023
  • Fig. 61 Strategic Framework
目次
Product Code: GVR-4-68040-412-3

Home Sleep Apnea Test Market Growth & Trends:

The global home sleep apnea test market size is expected to reach USD 3.38 billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to the increasing investment by prominent players, aimed at technological advancements in the home sleep apnea tests (HSAT). For instance, in March 2024, Belun Technology Company Ltd. launched a clinical trial aimed at the evaluation of the Belun Ring platform. The Belun Ring, a wearable technology, employs Artificial Intelligence (AI) to assist medical professionals in diagnosing Obstructive Sleep Apnea (OSA) and categorizing sleep phases. For home sleep assessments, individuals use this ring device, which incorporates a pulse oximeter and an accelerometer and is worn on the proximal index finger.

Moreover, the increasing prevalence of sleep apnea coupled with growing initiatives aimed at increasing awareness regarding the availability of technologically advanced solutions to treat sleep apnea is also contributing to the market growth. According to data published by the National Council on Aging, Inc. in May 2024 showcases that approximately 6 million Americans are formally diagnosed with sleep apnea; however, the condition is estimated to impact 30 million people within the U.S. The prevalence of sleep apnea tends to increase with age, the studies indicate that adults aged 65 and above exhibit a 56% higher risk of developing obstructive sleep apnea.

COVID-19 positively impacted the market as it forced the end users to adopt remote medical solutions. According to a survey conducted by Itamar Medical in partnership with Sleep Medicine Publication in March 2021 showcased that 29% of sleep clinics prioritize in-lab studies over at-home solutions-a proportion anticipated to decline further. This shift is supported by the adoption of disposable Home Sleep Apnea Tests (HSATs), which prevent the need for return shipping or equipment quarantine. Enhanced capabilities of home-based apnea tests, delivering instant results, further reduce the dependency on traditional in-lab studies for patient progression from initial screening through to diagnosis and treatment. During the pandemic, 67% of the clinics reported a moderate to significant reduction in in-lab patient studies, whereas 66% noted a comparable increase in the utilization of home sleep apnea tests. A substantial 65% of clinics foresee the continuation of this trend post-COVID, with a preference for HSATs as the primary diagnostic tool for sleep apnea.

Furthermore, key players in the market are adopting various strategies such as mergers & acquisitions, partnerships, collaborations, expansions, and new product launches to cater to the evolving demand of end users and strengthen their market positions. For instance, in March 2023, UK-based medical technology firm Acurable expanded its market reach by launching the AcuPebble device for the diagnosis of obstructive sleep apnea in the U.S. following recent FDA approval. Initially introduced in Europe in 2021, this device enhances the capability for remote, home-based sleep apnea testing, facilitating prompt diagnosis, accelerated treatment, and improved management of the condition.

Home Sleep Apnea Test Market Report Highlights:

  • North America held the largest market share of 47.74% in 2023. The market growth is attributed to a rising incidence of respiratory conditions, enhanced recognition of Obstructive Sleep Apnea (OSA), and supportive government policies that are fueling the market growth.
  • The market in Asia Pacific is expected to register the fastest growth rate at a CAGR of 8.0% from 2024 to 2030. The growth is attributed to the significant adoption of technologically advanced HSATs in the region.
  • Major players are employing various strategies such as product launches, collaborations, acquisitions, and mergers to expand their service portfolios and enhance their geographical presence, leading to significant competition within the market.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional scope
    • 1.1.2. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Home Sleep Apnea Test Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunity Analysis
  • 3.2. Home Sleep Apnea Test Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. COVID-19 Impact Analysis

Chapter 4. Home Sleep Apnea Test Market: Regional Estimates & Trend Analysis, By Product, By Application, By End Use

  • 4.1. Regional Market Share Analysis, 2023 & 2030
  • 4.2. Regional Market Dashboard
  • 4.3. Global Regional Market Snapshot
  • 4.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 4.5. North America
    • 4.5.1. U.S.
      • 4.5.1.1. Key country dynamics
      • 4.5.1.2. Regulatory framework/ reimbursement structure
      • 4.5.1.3. Competitive scenario
      • 4.5.1.4. U.S. market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.5.2. Canada
      • 4.5.2.1. Key country dynamics
      • 4.5.2.2. Regulatory framework/ reimbursement structure
      • 4.5.2.3. Competitive scenario
      • 4.5.2.4. Canada market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.5.3. Mexico
      • 4.5.3.1. Key country dynamics
      • 4.5.3.2. Regulatory framework/ reimbursement structure
      • 4.5.3.3. Competitive scenario
      • 4.5.3.4. Canada market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.6. Europe
    • 4.6.1. UK
      • 4.6.1.1. Key country dynamics
      • 4.6.1.2. Regulatory framework/ reimbursement structure
      • 4.6.1.3. Competitive scenario
      • 4.6.1.4. UK market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.2. Germany
      • 4.6.2.1. Key country dynamics
      • 4.6.2.2. Regulatory framework/ reimbursement structure
      • 4.6.2.3. Competitive scenario
      • 4.6.2.4. Germany market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.3. France
      • 4.6.3.1. Key country dynamics
      • 4.6.3.2. Regulatory framework/ reimbursement structure
      • 4.6.3.3. Competitive scenario
      • 4.6.3.4. France market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.4. Italy
      • 4.6.4.1. Key country dynamics
      • 4.6.4.2. Regulatory framework/ reimbursement structure
      • 4.6.4.3. Competitive scenario
      • 4.6.4.4. Italy market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.5. Spain
      • 4.6.5.1. Key country dynamics
      • 4.6.5.2. Regulatory framework/ reimbursement structure
      • 4.6.5.3. Competitive scenario
      • 4.6.5.4. Spain market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.6. Norway
      • 4.6.6.1. Key country dynamics
      • 4.6.6.2. Regulatory framework/ reimbursement structure
      • 4.6.6.3. Competitive scenario
      • 4.6.6.4. Norway market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.7. Sweden
      • 4.6.7.1. Key country dynamics
      • 4.6.7.2. Regulatory framework/ reimbursement structure
      • 4.6.7.3. Competitive scenario
      • 4.6.7.4. Sweden market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.8. Denmark
      • 4.6.8.1. Key country dynamics
      • 4.6.8.2. Regulatory framework/ reimbursement structure
      • 4.6.8.3. Competitive scenario
      • 4.6.8.4. Denmark market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.7. Asia Pacific
    • 4.7.1. Japan
      • 4.7.1.1. Key country dynamics
      • 4.7.1.2. Regulatory framework/ reimbursement structure
      • 4.7.1.3. Competitive scenario
      • 4.7.1.4. Japan market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.2. China
      • 4.7.2.1. Key country dynamics
      • 4.7.2.2. Regulatory framework/ reimbursement structure
      • 4.7.2.3. Competitive scenario
      • 4.7.2.4. China market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.3. India
      • 4.7.3.1. Key country dynamics
      • 4.7.3.2. Regulatory framework/ reimbursement structure
      • 4.7.3.3. Competitive scenario
      • 4.7.3.4. India market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.4. Australia
      • 4.7.4.1. Key country dynamics
      • 4.7.4.2. Regulatory framework/ reimbursement structure
      • 4.7.4.3. Competitive scenario
      • 4.7.4.4. Australia market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.5. South Korea
      • 4.7.5.1. Key country dynamics
      • 4.7.5.2. Regulatory framework/ reimbursement structure
      • 4.7.5.3. Competitive scenario
      • 4.7.5.4. South Korea market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.6. Thailand
      • 4.7.6.1. Key country dynamics
      • 4.7.6.2. Regulatory framework/ reimbursement structure
      • 4.7.6.3. Competitive scenario
      • 4.7.6.4. Singapore market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.8. Latin America
    • 4.8.1. Brazil
      • 4.8.1.1. Key country dynamics
      • 4.8.1.2. Regulatory framework/ reimbursement structure
      • 4.8.1.3. Competitive scenario
      • 4.8.1.4. Brazil market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.8.2. Argentina
      • 4.8.2.1. Key country dynamics
      • 4.8.2.2. Regulatory framework/ reimbursement structure
      • 4.8.2.3. Competitive scenario
      • 4.8.2.4. Argentina market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.9. MEA
    • 4.9.1. South Africa
      • 4.9.1.1. Key country dynamics
      • 4.9.1.2. Regulatory framework/ reimbursement structure
      • 4.9.1.3. Competitive scenario
      • 4.9.1.4. South Africa market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.9.2. Saudi Arabia
      • 4.9.2.1. Key country dynamics
      • 4.9.2.2. Regulatory framework/ reimbursement structure
      • 4.9.2.3. Competitive scenario
      • 4.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.9.3. UAE
      • 4.9.3.1. Key country dynamics
      • 4.9.3.2. Regulatory framework/ reimbursement structure
      • 4.9.3.3. Competitive scenario
      • 4.9.3.4. UAE market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.9.4. Kuwait
      • 4.9.4.1. Key country dynamics
      • 4.9.4.2. Regulatory framework/ reimbursement structure
      • 4.9.4.3. Competitive scenario
      • 4.9.4.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Billion)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 5.2. Company/Competition Categorization
  • 5.3. Key company market share/position analysis, 2023
  • 5.4. Company Profiles
    • 5.4.1. Resmed
      • 5.4.1.1. Company overview
      • 5.4.1.2. Financial performance
      • 5.4.1.3. Product benchmarking
      • 5.4.1.4. Strategic initiatives
    • 5.4.2. Itamar Medical Ltd a subsidiary of ZOLL Medical Corporation ( a ASAHI KASEI company)
      • 5.4.2.1. Company overview
      • 5.4.2.2. Financial performance
      • 5.4.2.3. Product benchmarking
      • 5.4.2.4. Strategic initiatives
    • 5.4.3. Cleveland Medical Devices Inc.
      • 5.4.3.1. Company overview
      • 5.4.3.2. Financial performance
      • 5.4.3.3. Product benchmarking
      • 5.4.3.4. Strategic initiatives
    • 5.4.4. Compumedics Limited
      • 5.4.4.1. Company overview
      • 5.4.4.2. Financial performance
      • 5.4.4.3. Product benchmarking
      • 5.4.4.4. Strategic initiatives
    • 5.4.5. Onera Technologies B.V.
      • 5.4.5.1. Company overview
      • 5.4.5.2. Financial performance
      • 5.4.5.3. Product benchmarking
      • 5.4.5.4. Strategic initiatives
    • 5.4.6. Sunrise
      • 5.4.6.1. Company overview
      • 5.4.6.2. Financial performance
      • 5.4.6.3. Product benchmarking
      • 5.4.6.4. Strategic initiatives
    • 5.4.7. Nox Medical
      • 5.4.7.1. Company overview
      • 5.4.7.2. Financial performance
      • 5.4.7.3. Product benchmarking
      • 5.4.7.4. Strategic initiatives
    • 5.4.8. Watermark Medical
      • 5.4.8.1. Company overview
      • 5.4.8.2. Financial performance
      • 5.4.8.3. Product benchmarking
      • 5.4.8.4. Strategic initiatives
    • 5.4.9. Bittium
      • 5.4.9.1. Company overview
      • 5.4.9.2. Financial performance
      • 5.4.9.3. Product benchmarking
      • 5.4.9.4. Strategic initiatives
    • 5.4.10. Cadwell Industries Inc.
      • 5.4.10.1. Company overview
      • 5.4.10.2. Financial performance
      • 5.4.10.3. Product benchmarking
      • 5.4.10.4. Strategic initiatives